Sesn1 (aka PA26) was originally identified as one of the p53 tumor suppressor target genes in a tetracycline-dependent manner (Buckbinder et al., 1994) and located in chromosome 6q21 (Velasco-Miguel et al., 1999). The gene discussed is TP53; the disease is neoplasm.